Results 151 to 160 of about 231,845 (277)

Felty Syndrome-Associated Clonal Cytotoxic T-Cell Disease With Terminal Aggressive Progression: Shared <i>STAT3</i> and <i>TET2</i> Mutations Across a Prolonged Disease Course. [PDF]

open access: yesEJHaem
ABSTRACT Introduction Biological overlap between Felty syndrome (FS) and clonal cytotoxic T‐cell disorders is increasingly recognized, but aggressive progression is uncommon. Methods We investigated an autopsy‐confirmed case of terminal aggressive clonal T‐cell disease that developed after a 4‐year clinical course diagnosed as FS using serial ...
Saito K   +11 more
europepmc   +2 more sources

A 13-week Dose Intensifying Simultaneous Combination Chemotherapy (DISC) Protocol for Malignant Lymphoma in Dogs [PDF]

open access: yes, 2010
Das maligne Lymphom ist die häufigste hämatopoetische Neoplasie des Hundes. Die chemotherapeutische Behandlung mit Doxorubicin-haltigen Protokollen wird als die Therapie der Wahl angesehen.
Zenker, Isabella
core  

Efficacy of Endoscopic Ultrasound‐guided Fine Needle Biopsy With Simplified Macroscopic On‐site Evaluation (With Video)

open access: yesDEN Open, Volume 7, Issue 1, April 2027.
ABSTRACT Background and Aims With advances in preoperative chemotherapy and comprehensive genomic profiling, endoscopic ultrasound‐guided fine needle biopsy (EUS‐FNB) has become vital for diagnosing pancreatic and peridigestive tract lesions. However, evidence remains limited regarding the performance of new‐generation puncture needles and simplified ...
Kento Shionoya   +13 more
wiley   +1 more source

Splenic marginal zone cell lymphoma involving liver and bone marrow. Report of a case with protracted follow-up, showing progressive disappearance of the lymphoma after splenectomy

open access: yesHaematologica, 1996
We report the case of a 42-year-old man who presented with B-symptoms, moderate splenomegaly and multiple nodules in the liver. Histologically, lymphocytic infiltrates were seen in the portal spaces and sinusoids of the liver and in the paratrabecular ...
R Rosso   +5 more
doaj  

Targeting B‐Cell‐Activating Factor and Its Receptor in Immune Thrombocytopenia and Warm Autoimmune Hemolytic Anemia

open access: yesAmerican Journal of Hematology, Volume 101, Issue 11, Page 2836-2852, November 2026.
ABSTRACT Current treatments for immune thrombocytopenia (ITP) and warm autoimmune hemolytic anemia (wAIHA), rare autoimmune diseases in which autoreactive B cells play a major role, can lead to high response rates; however, for many patients these responses are not durable or maintained after treatment discontinuation.
Matthieu Mahévas   +4 more
wiley   +1 more source

Severe ADEM‐Like Neuroinflammatory Disease and Cerebrovascular Fragility With Recurrent Pseudoaneurysms and Moyamoya in a Familial Germline CBL Mutation: Expanding the Clinical Phenotype

open access: yesAmerican Journal of Medical Genetics Part A, Volume 200, Issue 11, Page 2568-2574, November 2026.
ABSTRACT Heterozygous germline variants in CBL disrupt its function as a negative regulator of the Ras/MAPK pathway, classically predisposing to Juvenile myelomonocytic leukemia (JMML) and moyamoya. We describe two affected siblings carrying a paternally inherited CBL variant (c.1210 T> C, p.
Michal Bar‐Hakim   +12 more
wiley   +1 more source

What Is Your Diagnosis? Blood Smear From a Mixed‐Breed Dog

open access: yes
Veterinary Clinical Pathology, EarlyView.
Laura S. Peres   +5 more
wiley   +1 more source

Waiting Time Prioritisation for Public and Private Providers: Evidence From Hip Replacement Surgery

open access: yesHealth Economics, Volume 35, Issue 11, Page 1744-1763, November 2026.
ABSTRACT Waiting times for planned health care treatments have been increasing in England and other OECD countries. One policy to reduce the impact of waiting times on patients' health is for doctors to prioritise patients according to their health status. This study tests the extent to which publicly‐funded patients in poorer health are prioritised on
Panos Kasteridis   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy